Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer

Japanese Journal of Clinical Oncology

Volumn 32, Issue 5, 2002, Pages 162-166

  Bakan, Ebubekir ^a   Taysi, Seyithan ^a   Polat, M Fevzi ^a   Dalga, Sabahattin ^a   Umudum, Zuhal ^a   Bakan, Nuri ^a   Gumus, Metehan ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Free radicals; Gastric cancer; Lipid peroxidation; Malondialdehyde; Nitric oxide

Indexed keywords

MALONALDEHYDE; NITRATE; NITRATE REDUCTASE; NITRIC OXIDE; NITRITE; THIOBARBITURIC ACID; BIOLOGICAL MARKER; FREE RADICAL;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; STOMACH CARCINOMA; BLOOD; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; FREE RADICALS; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; NEOPLASM STAGING; NITRIC OXIDE; STOMACH NEOPLASMS;

EID: 0036561098     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/hyf035     Document Type: Article

References (36)

1. Forman D. Helicobacter pylori: the gastric cancer problem. Gut 1998;43 Suppl 1:833-4.
2. Durak I, Cetin R, Canbolat O, Cetin D, Yurtarslani Z, Unal A. Adenosine deaminase, 5′-nucleotidase, guanase and cytidine deaminase activities in gastric tissues from patients with gastric cancer. Cancer Lett 1994;84:199-202.
3. Carla B, Patrizia F, Sergio AT, Carla V, Francesco R, Antonia F. Vitamin E serum levels and gastric cancer: results from a cohort of patients in Tuscany, Italy. Cancer Lett 2000;151:15-8.
4. Ohshima H, Bartsch H. Chronic infections and inflammatory process as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994;305:253-64.
5. .) in the carcinogenic process. Biochim Biophys Acta 1996;1288:F31-6.
6. Kanner J, Harel S, Granit R. Nitric oxide as an antioxidant. Arch Biochem Biophys 1991;289:130-6.
7. Abu-Shakra A, McQueen ET, Cunnigham ML. Rapid analysis of base-pair substitutions induced by mutagenic drugs through their oxygen radical or epoxide derivatives. Mutat Res 2000;470:11-8.
8. Ignarro LJ, Buga GM, Wei LH, Bauer PM, Wu G, Soldato PD. Role of arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA 2001;98:4202-8.
9. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, et al. Role of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995;92:4392-6.
10. Mahesh SJ, Julie LP and Jack RLJR. Cellular antioxidant and pro-oxidant actions of nitric oxide. Free Rad Biol Med 1999;27:1357-66.
11. Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res 1994;54:1352-4.
12. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995;72:41-4.
13. Koh E, Noh SH, Lee YD, Lee HY, Han JW, Lee HW, et al. Differential expression of nitric oxide synthase in human stomach cancer. Cancer Lett 1999;146:173-80.
14. Goto T, Haruma K, Kitadai Y, Ito M, Yoshihara M, Sumii K, et al. Enhanced expression of inducible nitric oxide synthase and nitrotyrosine in gastric mucosa of gastric cancer patients. Clin Cancer Res 1999;5:1411-5.
15. Vakkala M, Kahlos K, Lakari E, Paakko P, Kinnula V, Soini Y. Inducible nitric oxide synthase expression, apoptosis and angiogenesis in in situ and invasive breast carcinomas. Clin Cancer Res 2000;6:2408-16.
16. Maeda H, Akaike T. Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry (USSR) 1998;63:854-65.
17. Samir M, el Kholy NM. Thiobarbituric acid reactive substances in patients with laryngeal cancer. Clin Otolaryngol 1999;24:232-4.
18. Seven A, Civelek S, Inci E, Korkut N, Burcak G. Evaluation of oxidative stress parameters in blood of patients with laryngeal carcinoma. Clin Biochem 1999;32:369-73.
19. Stone WL, Papas AM. Tocopherols and the etiology of colon cancer. J Nail Cancer Inst 1997;89:1006-14.
20. Sobin LH, Wittekind CH. In: Wittekind CH, editor. TNM Classification of Malignant Tumours, 5th ed. International Union Against Cancer. New York: Wiley-Liss 1997;59-62.
21. Alagöl H, Erdem E, Sancak B, Turkmen G, Camlibel M, Bugdayci G. Nitric oxide biosynthesis and malondialdehyde levels in advanced breast cancer. Aust N Z J Surg 1999;69:647-50.
22. Moshage H, Kok B, Huizenga JR, Jansen PLM. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem 1995;41:892-6.
23. Bories PN, Bories C. Nitrate determination in biological fluids by an enzymatic one step assay with nitrate reductase. Clin Chem 1995;41:904-7.
24. Hunter MIS, Nlemadim BC, Davidson DLW. Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients. Neurochem Res 1985;10:1645-52.
25. Haklar G, Sayin-Özveri E, Yüksel M, Aktan AÖ, Yalçin AS. Different kinds of reactive oxygen and nitrogen species were detected in colon and breast tumors. Cancer Lett 2001;165:219-24.
26. Doi C, Noguchi Y, Marat D, Saito A, Fukuzawa K, Yoshikawa T, et al. Expression of nitric oxide synthase in gastric cancer. Cancer Lett 1999;144:161-7.
27. Gerber M, Astre C, Segala C, Saintot M, Scali J, Simony-Lafontaine J, et al. Tumor progression and oxidant-antioxidant status. Cancer Lett 1997;114:211-4.
28. Mariyama A, Tabaru A, Unoki H, Abe S, Masumota A, Otsuki M. Plasma nitrite/nitrate concentrations as a tumor marker for hepatocellular carcinoma. Clin Chim Acta 2000;296:181-91.
29. Szaleczky E, Pronai L, Nakazawa H, Tulassay Z. Evidence of in vivo peroxynitrite formation in patients with colorectal carcinoma, higher plasma nitrite/nitrate levels, and lower protection against oxygen free radicals. J Clin Gastroenterol 2000;30:47-51.
30. Saintot M, Astre C, Pujol H, Gerber M. Tumor progression and oxidant-antioxidant status. Carcinogenesis 1996;17:1267-71.
31. Gerber M, Astre C, Segala C, Saintot M, Scali J, Simony-Lafontaine J, et al. Oxidant-antioxidant status alterations in cancer patients: relationship to tumor progression. J Nutr 1996;126(4 Suppl):1201S-7S.
32. Seven A, Erbil Y, Seven R, Inci F, Gulyasar T, Barutcu B, Candan G, et al. Breast cancer and benign breast disease patients evaluated in relation to oxidative stress. Cancer Biochem Biophys 1998;16:333-45.
33. Portakal O, Ozkaya O, Erden M, Bozan B, Kosan M, Sayek I. Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. Clin Biochem 2000;33:279-84.
34. Huang YL, Sheu JY, Lin TH. Association between oxidative stress and changes of trace elements in patients with breast cancer. Clin Biochem 1999;32:131-6.
35. Nagini S, Manoharan S, Ramachandran CR. Lipid peroxidations and antioxidants in oral squamous cell carcinoma. Clin Chim Acta 1998;273:95-8.
36. Choi MA, Kim BS, Yu R. Serum antioxidative vitamin levels and lipid peroxidation in gastric carcinoma patients. Cancer Lett 1999;136:89-93.